KLE cells represented poorly-differentiated endometrial tumor cells that harbor the frequently-occurring R175H p53 mutation, which inhibits normal p53 DNA binding function resulting in the loss of tumor suppressor activity and a gain of oncogenic activity. The gene discussed is TP53; the disease is endometrium neoplasm.